» Articles » PMID: 17989786

Genetic Selection of Low Fertile Onchocerca Volvulus by Ivermectin Treatment

Overview
Date 2007 Nov 9
PMID 17989786
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Onchocerca volvulus is the causative agent of onchocerciasis, or "river blindness". Ivermectin has been used for mass treatment of onchocerciasis for up to 18 years, and recently there have been reports of poor parasitological responses to the drug. Should ivermectin resistance be developing, it would have a genetic basis. We monitored genetic changes in parasites obtained from the same patients before use of ivermectin and following different levels of ivermectin exposure.

Methods And Findings: O. volvulus adult worms were obtained from 73 patients before exposure to ivermectin and in the same patients following three years of annual or three-monthly treatment at 150 microg/kg or 800 microg/kg. Genotype frequencies were determined in beta-tubulin, a gene previously found to be linked to ivermectin selection and resistance in parasitic nematodes. Such frequencies were also determined in two other genes, heat shock protein 60 and acidic ribosomal protein, not known to be linked to ivermectin effects. In addition, we investigated the relationship between beta-tubulin genotype and female parasite fertility. We found a significant selection for beta-tubulin heterozygotes in female worms. There was no significant selection for the two other genes. Quarterly ivermectin treatment over three years reduced the frequency of the beta-tubulin "aa" homozygotes from 68.6% to 25.6%, while the "ab" heterozygotes increased from 20.9% to 69.2% in the female parasites. The female worms that were homozygous at the beta-tubulin locus were more fertile than the heterozygous female worms before treatment (67% versus 37%; p = 0.003) and twelve months after the last dose of ivermectin in the groups treated annually (60% versus 17%; p<0.001). Differences in fertility between heterozygous and homozygous worms were less apparent three months after the last treatment in the groups treated three-monthly.

Conclusions: The results indicate that ivermectin is causing genetic selection on O. volvulus. This genetic selection is associated with a lower reproductive rate in the female parasites. We hypothesize that this genetic selection indicates that a population of O. volvulus, which is more tolerant to ivermectin, is being selected. This selection could have implications for the development of ivermectin resistance in O. volvulus and for the ongoing onchocerciasis control programmes.

Citing Articles

Survival of worm masses of Onchocerca ochengi in gerbils and hamsters: implications for the development of an in vivo macrofilaricide screening model.

Ayiseh R, Mbah G, Manfo F, Kulu T, Njotu F, Monya E Parasitol Res. 2023; 122(7):1581-1591.

PMID: 37154921 DOI: 10.1007/s00436-023-07859-7.


Concern for and Macrocyclic Lactone Loss of Efficacy: Current Situation in the USA and Europe, and Future Scenarios.

Diakou A, Prichard R Pathogens. 2021; 10(10).

PMID: 34684273 PMC: 8541013. DOI: 10.3390/pathogens10101323.


Onchocerca volvulus bivalent subunit vaccine induces protective immunity in genetically diverse collaborative cross recombinant inbred intercross mice.

Ryan N, Hess J, Pardo-Manuel de Villena F, Leiby B, Shimada A, Yu L NPJ Vaccines. 2021; 6(1):17.

PMID: 33500417 PMC: 7838260. DOI: 10.1038/s41541-020-00276-2.


The Mbam drainage system and onchocerciasis transmission post ivermectin mass drug administration (MDA) campaign, Cameroon.

Abong R, Amambo G, Hamid A, Enow B, Beng A, Nietcho F PLoS Negl Trop Dis. 2021; 15(1):e0008926.

PMID: 33465080 PMC: 7815102. DOI: 10.1371/journal.pntd.0008926.


Heterogeneous response of Wuchereria bancrofti-infected persons to diethylcarbamazine (DEC) and its implications for the Global Programme to Eliminate Lymphatic Filariasis (GPELF).

Sankari T, Subramanian S, Hoti S, Pani S, Jambulingam P, Das P Parasitol Res. 2020; 120(1):311-319.

PMID: 33146778 DOI: 10.1007/s00436-020-06950-7.


References
1.
Grant W . What is the real target for ivermectin resistance selection in Onchocerca volvulus?. Parasitol Today. 2000; 16(11):458-9; discussion 501-2. DOI: 10.1016/s0169-4758(00)01804-4. View

2.
Prichard R . Is anthelmintic resistance a concern for heartworm control? What can we learn from the human filariasis control programs?. Vet Parasitol. 2005; 133(2-3):243-53. DOI: 10.1016/j.vetpar.2005.04.008. View

3.
Awadzi K, Attah S, Addy E, Opoku N, Quartey B, Lazdins-Helds J . Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol. 2004; 98(4):359-70. DOI: 10.1179/000349804225003442. View

4.
Williams R . A note on robust variance estimation for cluster-correlated data. Biometrics. 2000; 56(2):645-6. DOI: 10.1111/j.0006-341x.2000.00645.x. View

5.
Gardon J, Boussinesq M, Kamgno J, Gardon-Wendel N, Demanga-Ngangue , Duke B . Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial. Lancet. 2002; 360(9328):203-10. DOI: 10.1016/S0140-6736(02)09456-4. View